Hardat Ramprasad Singh, widely recognized as Hardat Singh, was born and raised in the culturally vibrant city of Georgetown, Guyana. From his childhood, Hardat demonstrated an innate curiosity and passion for science, particularly in the medical and biological fields. This early enthusiasm laid the foundation for what would become a pioneering career in medicine, biotechnology, and diagnostics.
At the age of 14, Hardat Singh emigrated to New York, USA, embarking on a journey of academic and professional development that spanned continents. His education was uniquely shaped by experiences both in New York and Mumbai, India, where he specialized in the vital medical disciplines of Anesthesia and Immunology. This international education enriched his expertise and equipped him with a broad and nuanced perspective of healthcare and medical research.
Hardat Singh’s formal training began in New York, where he focused on anesthesia — a critical component of surgical care that requires deep knowledge of human physiology and patient safety. His education continued in Mumbai, India, where he further specialized in immunology, gaining insights into the body’s defense mechanisms and the complexities of immune responses.
This dual focus on anesthesia and immunology uniquely positioned Hardat Singh to understand both patient care and the scientific underpinnings of disease and treatment. His academic achievements set the stage for a lifelong commitment to advancing medical knowledge and improving patient outcomes.
Hardat Singh’s professional career is marked by decades of hands-on experience in multiple prominent medical institutions throughout New York and the surrounding metropolitan area. His work encompassed a wide range of clinical and research roles, enabling him to gain expertise across medical disciplines and build a reputation for excellence and innovation.
In 1988, Hardat Singh founded HDM Labs Inc., an enterprise born out of his vision to innovate and lead in the medical diagnostics and biotechnology fields. Headquartered in New York, with strategic distribution offices in Guyana and Suriname, HDM Labs serves as a vital bridge between cutting-edge science and the medical research community in the Americas and the Caribbean.
Under Hardat Singh’s stewardship, HDM Labs Inc. became known for its specialization in the manufacturing and global distribution of essential biological products, including:
These products play a crucial role in In Vitro Diagnostics (IVD), enabling accurate, reliable, and rapid testing in clinical and research laboratories worldwide.
HDM Labs Inc. operates with full compliance and approval from the United States Food and Drug Administration (FDA), a testament to the company's commitment to maintaining the highest standards of quality, safety, and efficacy in its products and operations.
As the visionary President and CEO of HDM Labs Inc., Hardat Singh has fostered partnerships and collaborations on a global scale, extending HDM Labs’ influence in multiple sectors, including:
His strategic leadership has ensured that HDM Labs plays a critical role in the global healthcare supply chain, contributing to the availability of high-quality medical products that impact patient care worldwide.
Hardat Singh is celebrated not only as a pioneer in the field of In Vitro Diagnostics but also as a trailblazer representing Guyana and the broader Caribbean region on the international scientific stage. He is recognized as the first from his region to specialize in such an advanced and impactful field, breaking barriers and setting new standards for excellence.
His legacy is built on groundbreaking work that bridges biotechnology, medicine, and diagnostics—improving healthcare standards and inspiring future generations of scientists, researchers, and healthcare professionals.
Hardat Singh is driven by the belief that innovation in biotechnology can profoundly transform healthcare delivery. His philosophy centers on:
Stay connected and follow Hardat Singh’s ongoing work, insights, and contributions through his official social media channels: